These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 445407)

  • 1. Different effects of vincristine on methotrexate uptake by L1210 cells and mouse intestinal epithelia in vitro and in vivo.
    Chello PL; Sirotnak FM; Dorick DM
    Cancer Res; 1979 Jun; 39(6 Pt 1):2106-12. PubMed ID: 445407
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of therapeutic synergism between vincristine and methotrexate in L1210 murine leukemia in vivo.
    Bender RA; Nichols AP; Norton L; Simon RM
    Cancer Treat Rep; 1978 Jul; 62(7):997-1003. PubMed ID: 688252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic relevance of differences in the structural specificity of the transport systems for folate analogs in L1210 tumor cells and in isolated murine intestinal epithelial cells.
    Chello PL; Sirotnak FM; Dorick DM; Donsbach RC
    Cancer Res; 1977 Dec; 37(12):4297-303. PubMed ID: 922722
    [No Abstract]   [Full Text] [Related]  

  • 4. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia.
    Chello PL; Sirotnak FM; Dorick DM; Moccio DM
    Cancer Treat Rep; 1979; 63(11-12):1889-94. PubMed ID: 526921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose methotrexate therapy with citrovorum factor: a pharmacologic perspective in murine tumor models.
    Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
    Cancer Treat Rep; 1977 Jul; 61(4):565-74. PubMed ID: 301778
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
    Chello PL; Sirotnak FM
    Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.
    Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
    Cancer Res; 1976 Dec; 36(12):4672-8. PubMed ID: 1000510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia.
    Zager RF; Frisby SA; Oliverio VT
    Cancer Res; 1973 Jul; 33(7):1670-6. PubMed ID: 4124487
    [No Abstract]   [Full Text] [Related]  

  • 11. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
    Pouillart P; Huong TH; Lhéritier J
    Bull Cancer; 1974; 61(4):509-26. PubMed ID: 4458834
    [No Abstract]   [Full Text] [Related]  

  • 12. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
    Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
    Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved methotrexate therapy of murine tumors obtained by probenecid-mediated pharmacological modulation at the level of membrane transport.
    Sirotnak FM; Moccio DM; Hancock CH; Young CW
    Cancer Res; 1981 Oct; 41(10):3944-9. PubMed ID: 7285003
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristics of the vincristine-induced augmentation of methotrexate uptake in Ehrlich ascites tumor cells.
    Fyfe MJ; Goldman ID
    J Biol Chem; 1973 Jul; 248(14):5067-73. PubMed ID: 4736889
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of chemotherapeutic agents with methotrexate and 5-fluorouracil and its effect on de novo DNA synthesis.
    Bruckner HW; Schreiber C; Waxman S
    Cancer Res; 1975 Mar; 35(3):801-6. PubMed ID: 1116135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the transport mechanism for methotrexate in L1210 mouse leukemia cells.
    Henderson GB
    Prog Clin Biol Res; 1983; 132B():415-23. PubMed ID: 6634763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
    Pouillart R; Huong TH; Brugerie E; Lheritier J
    Biomedicine; 1974 Dec; 21(12):471-9. PubMed ID: 4462870
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of DNA synthesis and enhancement of the uptake and action of methotrexate by low-power-density microwave radiation in L1210 leukemia cells.
    Chang BK; Huang AT; Joines WT
    Cancer Res; 1980 Apr; 40(4):1002-5. PubMed ID: 7357530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.
    Valeriote F; Vietti T; Coulter D
    J Natl Cancer Inst; 1980 Apr; 64(4):801-5. PubMed ID: 6928994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of conditions in which dipyridamole enhances methotrexate toxicity in L1210 cells.
    Muggia FM; Slowiaczek P; Tattersall MH
    Anticancer Res; 1987; 7(2):161-6. PubMed ID: 3592628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.